Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2024

SOBRsafe Inc. (NASDAQ: SOBR) Sets New Standards for Monitoring and Managing Alcohol Compliance with the Launch of Its Revolutionary Alcohol Detection Software

SOBRsafe (NASDAQ: SOBR), a Colorado-based provider of next-generation transdermal alcohol detection technology, has just announced the launch of its fully integrated enterprise software solution that is expected to transform how health providers monitor and manage alcohol compliance. Designed to complement … Continue reading

Posted in SOBRsafe Inc. SOBR | Leave a comment

MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Expands OPKO Product Promotion at Asia’s Largest Health Expo in China

NextPlat (NASDAQ: NXPL, NXPLW) announced its participation in the 2024 China International Natural Health & Nutrition Expo (“NHNE”) in Wuhan, showcasing OPKO Health Europe products, including new veterinary and animal care offerings. Supported by its in-country marketing partner, NextPlat has … Continue reading

Posted in NextPlat Corp. NXPL | Leave a comment

The Safe-Haven Asset Crypto Investors Are Missing

In recent years, cryptocurrency has captured the imagination of investors, who have embraced it as a revolutionary asset class offering high-growth potential. With Bitcoin and other digital currencies reaching new heights, many investors have turned to the crypto market as … Continue reading

Posted in McEwen Mining Inc. MUX | Leave a comment

MissionIRNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Marks Pivotal Step to Enhance Operational Capabilities, Secure Offtake Agreement

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM), the operator and majority owner of the Waterberg Project, recently announced an important collaboration with Ajlan & Bros Mining and Metals Co. to explore establishing a standalone platinum group metals (“PGM”) … Continue reading

Posted in Platinum Group Metals Ltd. PLG | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin Amid Strong Financial Position

CNS Pharmaceuticals (NASDAQ: CNSP) reported Q3 2024 financial results and highlighted clinical advancements, including the ongoing potentially pivotal trial of Berubicin, a targeted chemotherapy for recurrent glioblastoma multiforme (“GBM”). Enrollment of 252 patients was completed, with primary analysis data expected … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Partners with National Auto Fleet Group to Deliver Bollinger B4 EV Trucks to Government Fleets

Mullen Automotive (NASDAQ: MULN) announced a partnership with National Auto Fleet Group (“NAFG”) to sell its all-electric Class 4 Bollinger B4 commercial trucks to government agencies via NAFG’s Sourcewell-awarded contract. The Bollinger B4, designed with fleet and upfitter input, offers … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Reports Q3 Financials, Highlights Growth from Progressive Care and Outfitter Satellite Acquisitions

NextPlat (NASDAQ: NXPL, NXPLW)  reported Q3 2024 results reflecting the impact of its recent acquisitions, including Progressive Care and Outfitter Satellite, which contributed to consolidated revenues of $15.4 million. While healthcare revenue declined due to lower prescription reimbursement rates, e-Commerce … Continue reading

Posted in NextPlat Corp. NXPL | Leave a comment

MissionIRNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) – A Gem in the Mining Sector

McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned to benefit from increased investor interest in precious metals as well as growing demand for critical minerals. “McEwen Mining is a gold and silver producer with operations across the Americas, including Nevada, … Continue reading

Posted in McEwen Mining Inc. MUX | Leave a comment

Annovis Bio Inc. (NYSE: ANVS) Concludes Q3 with Strategic Milestones and FDA-Cleared Phase 3 Program for Alzheimer’s Disease

Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), concluded the third quarter with significant milestones achieved and a clear path forward for its … Continue reading

Posted in Annovis Bio Inc. ANVS | Leave a comment

Kairos Pharma Ltd. (NYSE American: KAPA) Is ‘One to Watch’

Kairos Pharma (NYSE American: KAPA) is a clinical-stage biopharmaceutical company focused on advancing innovative oncology therapeutics that target drug resistance and immune suppression, two significant barriers in effective cancer treatment. By addressing these mechanisms, Kairos aims to restore the efficacy … Continue reading

Posted in Kairos Pharma Ltd. KAPA | Leave a comment